NCT05072691View on ClinicalTrials.gov

Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

January 1, 2030

Study Completion Date

January 1, 2030

Conditions
Multiple Sclerosis
Interventions
DIAGNOSTIC_TEST

CSF immunoglobulin (Ig) free light chains (FLC) dosage

CSF immunoglobulin (Ig) free light chains (FLC) dosage in the peripheral blood and cerebrospinal fluid.

Trial Locations (1)

1020

RECRUITING

CHU Brugmann, Brussels

All Listed Sponsors
lead

Francis Corazza

OTHER